Methadone metabolites (EDDP) antibody and antigen (hapten, BSA/OVA conjugated)

Diagnostic anti-Methadone metabolites (EDDP) antibodies (anti-Methadone metabolites, anti-EDDP) and diagnostic hapten-carrier conjugates BSA-Methadone metabolites (EDDP), OVA-Methadone metabolites (EDDP), KLH-Methadone metabolites (EDDP) antigens for Pain EDDP detection in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Target products collectionGo to Pain diagnostics products collection>>


Product information

Catalog No.DescriptionUS $ Price (per mg)
GMP-SMT-229-Ag01BSA-Methadone metabolites (EDDP)$756.00
GMP-SMT-229-Ag02OVA-Methadone metabolites (EDDP)$756.00
GMP-SMT-229-Ab01Anti-human Methadone metabolites (EDDP) mouse monoclonal antibody (mAb)$1953.00
GMP-SMT-229-Ab02Anti-human Methadone metabolites (EDDP) human monoclonal antibody (mAb)$1953.00

Size: 1mg | 10mg | 100mg



Product Description

BSA-Methadone metabolites (EDDP)

Cat No.GMP-SMT-229-Ag01
Product NameBSA-Methadone metabolites (EDDP)
TargetMethadone metabolites (EDDP)
Expression platformSynthetic
Bioactivity validationMethadone metabolites (EDDP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in EDDP level test of Pain and related syndrome evaluation
Products descriptionCompetitive immunoassay-validated hapten-carrier conjugates BSA-Methadone metabolites (EDDP) / OVA-Methadone metabolites (EDDP) is Synthetic.
PurityHigh (TBD)
ApplicationCompetitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

OVA-Methadone metabolites (EDDP)

Cat No.GMP-SMT-229-Ag02
Product NameOVA-Methadone metabolites (EDDP)
TargetMethadone metabolites (EDDP)
Expression platformSynthetic
Bioactivity validationMethadone metabolites (EDDP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in EDDP level test of Pain and related syndrome evaluation
Products descriptionCompetitive immunoassay-validated hapten-carrier conjugates BSA-Methadone metabolites (EDDP) / OVA-Methadone metabolites (EDDP) is Synthetic.
PurityHigh (TBD)
ApplicationCompetitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Anti-human Methadone metabolites (EDDP) mouse monoclonal antibody (mAb)

Cat No.GMP-SMT-229-Ab01
Product NameAnti-human Methadone metabolites (EDDP) mouse monoclonal antibody (mAb)
TargetMethadone metabolites (EDDP)
Expression platformhybridoma
IsotypesMouse IgG
Bioactivity validationMethadone metabolites (EDDP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Methadone metabolites (EDDP) antibodies in EDDP level test of Pain and related syndrome evaluation.
TagmFc
Products descriptionAnti-human Methadone metabolites (EDDP) mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by hybridoma technology.
PurityHigh (TBD)
ApplicationCompetitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Anti-human Methadone metabolites (EDDP) human monoclonal antibody (mAb)

Cat No.GMP-SMT-229-Ab02
Product NameAnti-human Methadone metabolites (EDDP) human monoclonal antibody (mAb)
TargetMethadone metabolites (EDDP)
Expression platformhybridoma
IsotypesHuman IgG1
Bioactivity validationMethadone metabolites (EDDP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Methadone metabolites (EDDP) antibodies in EDDP level test of Pain and related syndrome evaluation.
TaghFc
Products descriptionAnti-human Methadone metabolites (EDDP) mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO.
PurityPurity: ≥95% (SDS-PAGE)
ApplicationCompetitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
FormulationSupplied as a 0.2 μM filtered solution of PBS, PH7.4.
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Target/Biomarker information


    1. Introduction to Methadone Metabolites in In Vitro Diagnosis (IVD)

    Methadone, a potent opioid medication, is indispensable in pain management and opioid addiction treatment. In the realm of in vitro diagnosis (IVD), Methadone metabolites emerge as critical players, shedding light on the intricate processes governing Methadone metabolism within the human body. This comprehensive exploration delves into the multifaceted role of Methadone metabolites within IVD, elucidating their crucial applications, methodologies, and the profound significance of their measurement.

    2. The Significance of Methadone Metabolites in IVD

    Methadone metabolites serve as invaluable biomarkers, offering profound insights into Methadone therapy's dynamics. They enable a precise understanding of how the body processes Methadone and its associated metabolites. By scrutinizing Methadone metabolite levels within patient samples, IVD facilitates precise treatment monitoring and optimization, enhancing the therapeutic outcomes of Methadone-based interventions.

    3. Assessment of Treatment Efficacy

    Quantifying Methadone metabolites is instrumental in assessing the effectiveness of Methadone therapy. Methadone metabolite levels provide an empirical measure of the medication's impact, allowing healthcare providers to gauge whether patients are receiving an appropriate dosage for pain management or addiction treatment. This insight is invaluable in fine-tuning treatment regimens to ensure optimal results.

    4. Validation of Patient Adherence

    Methadone metabolite measurement corroborates patient adherence to prescribed Methadone regimens. Discrepancies in metabolite levels may signify non-compliance or misuse, alerting healthcare providers to potential challenges in patient adherence. This knowledge empowers clinicians to tailor interventions and support strategies accordingly.

    5. Tailoring Therapeutics through Metabolite Analysis

    The quantification of Methadone metabolites facilitates the customization of treatment plans. By aligning Methadone dosages precisely with individual patient requirements, healthcare providers optimize therapeutic outcomes while minimizing the risk of adverse effects or overdose. This personalized approach exemplifies the principles of precision medicine.

    6. Detection of Diversion and Misuse

    Within the context of opioid addiction treatment, Methadone metabolite testing serves as a vigilant sentinel against diversion and misuse. By measuring metabolite levels, healthcare providers can identify cases where Methadone is not being used for its intended purpose. This is pivotal in ensuring the medication remains dedicated to the treatment of addiction, minimizing its potential for illicit use.

    7. Forensic and Legal Implications

    Beyond clinical applications, Methadone metabolite analysis assumes paramount significance in forensic and legal domains. It substantiates evidence of Methadone use, playing a central role in legal proceedings, workplace drug testing, and other scenarios where the verification of Methadone exposure is required.

    8. Conclusion: Methadone Metabolites in IVD - Paving the Way for Informed Decision-Making

    In conclusion, Methadone metabolites are integral components of IVD, enhancing the precision and effectiveness of Methadone therapy. Their measurement empowers healthcare providers to assess treatment efficacy, validate patient adherence, and avert potential misuse. Additionally, in legal and forensic contexts, Methadone metabolite analysis offers critical insights into Methadone use, fostering informed decision-making and reinforcing the integrity of therapeutic interventions. Methadone metabolites, in their multifaceted role, continue to shape the landscape of IVD, ensuring that Methadone-based treatments are optimized for patient welfare.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.